Kristen N. Balogh

A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer

Patrick A. Ott, Siwen Hu‐Lieskovan, Bartosz Chmielowski et al. · Cell · 2020 · 699 citations · Full text

Urology, Medicine, Phase Ib Trial +6

Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer

Mark M. Awad, Ramaswamy Govindan, Kristen N. Balogh et al. · Cancer Cell · 2022 · 200 citations

Medicine, Immunology, Therapeutic Vaccine +11

Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses

Kristen N. Balogh, Dennis J. Templeton, Janet V. Cross · PLoS ONE · 2018 · 104 citations · Full text

T-regulatory Cell, Immunology, Cell Death +17

Combined TCR Repertoire Profiles and Blood Cell Phenotypes Predict Melanoma Patient Response to Personalized Neoantigen Therapy plus Anti-PD-1

Asaf Poran, Julian Scherer, Meghan E. Bushway et al. · Cell Reports Medicine · 2020 · 45 citations · Full text

Tcr Repertoires, Immunology, Immune Cell Therapy +17

Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial

Jessica S.W. Borgers, Divya Lenkala, Victoria Kohler et al. · Nature Medicine · 2025 · 32 citations · Full text